Effects of l-tetrahydropalmatine on locomotor sensitization to oxycodone in mice

被引:39
作者
Liu, YL
Liang, JH
Yan, LD
Su, RB
Wu, CF
Gong, ZH [1 ]
机构
[1] Beijing Inst Pharmacol & Toxicol, Beijing 100850, Peoples R China
[2] Shenyang Pharmaceut Univ, Dept Pharmacol, Shenyang 110016, Peoples R China
[3] Peking Univ, Natl Inst Drug Dependence, Dept Neuropharmacol, Beijing 100083, Peoples R China
关键词
l-tetrahydropalmatine; oxycodone; locomotor sensitization;
D O I
10.1111/j.1745-7254.2005.00101.x
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Aim: Recent studies have shown that 1-tetrahydropalmatine (l-THP), an active component of Corydolis yanhusuo, can inhibit the development of the conditional place preference induced by opioid receptor agonists, but the effects of l-THP on locomotor sensitivity induced by opioid receptor agonists have not been documented. In the present study, the effects of l-THP on locomotor sensitization to oxycodone, which is an opioid receptor agonist, were studied. Methods: Mice treated daily for 7 d with 5 mg/kg oxycodone and challenged with the same dose after 5 days of washout showed locomotor sensitization. In order to study the effects of l-THP on locomotor sensitization induced by oxycodone, l-THP was administered at doses of 6.25, 12.5, and 18.75 mg/kg, 40 min prior to treatment of oxycodone. Results: l-THP per se did not affect the locomotor activity at the doses of 6.25, 12.5, and 18.75 mg/kg, but could antagonize the hyperactivity induced by oxycodone (5 mg/kg). Co-administration of l-THP (18.75 mg/kg), 40 min prior to oxycodone, could inhibit the development of sensitization to oxycodone. In addition, l-THP (6.25, 12.5, and 18.75 mg/kg, ig) dose-dependently prevented the expression of oxycodone sensitization. Conclusion: These results suggested that l-THP could attenuate the locomotor-stimulating effects of oxycodone and inhibit the development and expression of oxycodone behavioral sensitization.
引用
收藏
页码:533 / 538
页数:6
相关论文
共 29 条
[1]   CALCIUM-CHANNEL INHIBITORS PREVENT APOMORPHINE-INDUCED AND OXYTOCIN-INDUCED PENILE ERECTION AND YAWNING IN MALE-RATS [J].
ARGIOLAS, A ;
MELIS, MR ;
GESSA, GL .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1989, 166 (03) :515-518
[2]  
Cheng JALM, 1996, ENDOD DENT TRAUMATOL, V12, P25
[3]   SOME CENTRAL PHARMACOLOGICAL EFFECTS OF THE CALCIUM-CHANNEL ANTAGONIST FLUNARIZINE [J].
CZYRAK, A ;
MOGILNICKA, E ;
MAJ, J .
JOURNAL OF NEURAL TRANSMISSION-GENERAL SECTION, 1991, 83 (03) :179-188
[4]   Drug-induced reinstatement of heroin- and cocaine-seeking behaviour following long-term extinction is associated with expression of behavioural sensitization [J].
De Vries, TJ ;
Schoffelmeer, ANM ;
Binnekade, R ;
Murder, AH ;
Vanderschuren, LJMJ .
EUROPEAN JOURNAL OF NEUROSCIENCE, 1998, 10 (11) :3565-3571
[5]   ATYPICAL WITHDRAWAL SYNDROME (ORGANIC DELUSIONAL SYNDROME) SECONDARY TO OXYCODONE DETOXIFICATION [J].
FISHBAIN, DA ;
GOLDBERG, M ;
ROSOMOFF, RS ;
ROSOMOFF, H .
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 1988, 8 (06) :441-442
[6]  
GE XQ, 1999, CHIN J DRUG DEPEND, V8, P178
[7]   DOSE-RANGING STUDY OF OXYCODONE FOR CHRONIC PAIN IN ADVANCED CANCER [J].
GLARE, PA ;
WALSH, TD .
JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (05) :973-978
[8]  
Huang K, 1999, ACTA PHARMACOL SIN, V20, P907
[10]  
JIN GZ, 2001, DISCOVERIES VOYAGE C, P351